MedTrace Logo

Evaluation of Two Mini-Implant Lengths in the Infra-Zygomatic Crest Region

NCT06293872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-03-05

No results posted yet for this study

Summary

Evaluation of two different lengths of mini-implants in the infrazygomatic area regarding primary stability, pain perception, sinus penetration, secondary stability and failure rate.

Conditions

  • Orthodontic Appliance Complication

Interventions

DEVICE

12*2 mm length miniscrew

Prior to mini-inplant insertion the patient will instructed to rinse mouth with chlorhexidine mouthwash, then local anesthesia will be applied. The clinical implication for miniscrew insertion in the IZ crest of adults is 14 to 16 mm above the maxillary occlusal plane and the maxillary first molar. The self-drilling screw is directed at 90° to the occlusal plane at this point. After the initial notch in the bone is created after couple of turns to the driver, the bone screw driver direction is changed by 55°-70° toward the tooth, downward, which aid in bypassing the roots of the teeth and directing the screw to the infra-zygomatic area of the maxilla. The bone screw is screwed until only the head of the screw is visible outside the alveolar mucosa. Follow-up: C.B.C.T will be performed after surgery to verify the implant position relative to the adjacent roots

Sponsors & Collaborators

  • University of Baghdad

    lead OTHER

Principal Investigators

  • Mehdi abd Alrubayee, B.D.S; M.Sc; PhD · Assistant Professor, Department of Orthodontics, College of Dentistry, University of Baghdad, Iraq.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-25
Primary Completion
2023-07-10
Completion
2023-12-28

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06293872 on ClinicalTrials.gov